Christopher Robinson/LinkedIn
Oct 26, 2025, 08:36
Christopher Robinson: Aspirin Prophylaxis Did Not Reduce Preterm Preeclampsia
Christopher Robinson, Associate Professor of Maternal Fetal Medicine at the University of South Carolina, posted on LinkedIn:
”Early risk assessment and aspirin prophylaxis did not reduce preterm preeclampsia in Sweden: a population-based study.”
Title: Early risk assessment and aspirin prophylaxis did not reduce preterm preeclampsia in Sweden: a population-based study
Authors: Núria Mans-Gallart, Sara Carlhäll, Eric Hildebrand, Daniel Axelsson, Caroline Lilliecreutz
Read the full article here.
Stay informed with Hemostasis Today.
-
Dec 19, 2025, 13:30PPTA Europe’s Holiday Message: Wishing Health, Rest, and Renewal for 2026
-
Dec 19, 2025, 13:22If You Were Reading a “Bible for Blood Donation Volunteers,” What’s the ONE Thing That Must Be in It?
-
Dec 19, 2025, 12:52Julia Owens: Stroke Remains One of the World’s Leading Causes of Death and Disability
-
Dec 19, 2025, 12:03Pradeep Natarajan: Our New Genetic Study of Aortic Stenosis in ~3M
-
Dec 19, 2025, 11:47ESO Blog: Anna Gardin on Stroke Risk in the Era of Climate Extremes
-
Dec 19, 2025, 10:51Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
-
Dec 19, 2025, 10:08Camilla Lombardi Shares an EHC Nutrition Guide for People with Bleeding Disorders
-
Dec 19, 2025, 09:56Danny Hsu Shares The ”I-WISh” Study by Nichola Cooper on ITP
-
Dec 19, 2025, 09:39Paul Bolaji: A Landmark Achievement -The Historic 1st Nigerian Stroke Leaders’ Summit 2025